HRT Financial’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

HRT Financial’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-23,811	Closed	-$15K	–	3257
2023 Q3	$15K	Buy	+23,811	New	+$29.2K	﹤0.01%	2094
2023 Q1	–	Sell	-7,038	Closed	-$82K	–	3360
2022 Q4	$82K	Buy	7,038 +4,312	+158%	+$76.1K	﹤0.01%	2086
2022 Q3	$57K	Sell	2,726 -7,538	-73%	-$203K	﹤0.01%	2433
2022 Q2	$248K	Buy	+10,264	New	+$349K	﹤0.01%	2143
2022 Q1	–	Sell	-2,729	Closed	-$191K	–	4049
2021 Q4	$191K	Sell	2,729 -11,024	-80%	-$929K	﹤0.01%	2552
2021 Q3	$1.28M	Sell	13,753 -3,198	-19%	-$304K	0.01%	1059
2021 Q2	$1.7M	Buy	16,951 +13,556	+399%	+$1.32M	0.02%	712
2021 Q1	$316K	Buy	+3,395	New	+$344K	﹤0.01%	2071

Other funds holding VBIV

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

HRT Financial's VBIV Position: Q4 2023 in Review

HRT Financial sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q4 2023, closing a stake of 23,811 shares — an estimated $15K sold.

HRT Financial first reported a position in VBIV in Q1 2021 and held it in 8 quarters. The position peaked at $1.7M in Q2 2021. 39 funds tracked by Wall St. Rank hold VBIV as of Q4 2023.

HRT Financial reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q4 2023 after selling out during the quarter.
HRT Financial sold 23,811 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q4 2023, an estimated $15K.
HRT Financial first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q1 2021 and held it in 8 quarters.
HRT Financial's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $1.7M in Q2 2021.
39 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q4 2023.

Based on HRT Financial's 13F filing for Q4 2023, filed 9 Feb 2024.